Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
Rev. bras. ter. intensiva; 32 (2), 2020
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Infections à coronavirus/traitement médicamenteux, Aminoquinoléines/usage thérapeutique, Oséltamivir/usage thérapeutique, Lopinavir/usage thérapeutique, Ritonavir/usage thérapeutique, Hormones corticosurrénaliennes/usage thérapeutique, Héparine/usage thérapeutique, Antibactériens/usage thérapeutique, Betacoronavirus/effets des médicaments et des substances chimiques, Pneumopathie virale/traitement médicamenteux, Pandémies/prévention et contrôle